Exact Sciences Shares Data Around Predicting Radiation Therapy Benefits
POLAR is a genomic signature that is both prognostic for the risk of local regional recurrence and predictive of radiotherapy benefit.
More Breast Cancer Patients Can Choose Smaller Surgery
In the past, doctors would say these women needed mastectomies.
December 9, 2022
Pausing Breast Cancer Treatment for Pregnancy Appears Safe
Partridge estimates 6,000 U.S. women a year want to get pregnant but must take hormone-blocking drugs.
December 8, 2022
Using Math to Better Treat Cancer
This new algorithm can generalize the differing radiation resistances of stem cells and non-stem cells.
November 30, 2022
AnchorDx Enrolls First Patient for Bladder Cancer Assay Clinical Trial
UriFind is a urine-based, non-invasive molecular test for accurate detection of bladder cancer.
November 23, 2022
Opna Bio Raises $38M for Advance Novel Oncology Discovery Program
The proceeds will be used to develop novel fragile-X mental retardation protein (FMRP) inhibitors.
November 21, 2022
Calyx Medical Imaging Advances Neuro-oncology Treatment Development
November 17, 2022
Ibex Medical Secures $10M for AI-Based Cancer Diagnostics
November 9, 2022
OncoPrecision Raises $3.3M for Its Patient Micro Avatar Technology
October 31, 2022
NeoNavia Biopsy System Launching in the U.S.
October 25, 2022
Mevion Introduces New Proton Therapy System
Thanks to the compact size, the FIT system will further reduce the cost and complexity of proton therapy.
October 21, 2022
RefleXion Highlights New Cancer Treatment Research
The company will present during the American Society for Radiation Oncology (ASTRO) 2022 Annual Meeting.
October 20, 2022
GE, Tribun Health to Better Integrate Digital Pathology Images
It is expected to focus on making digital pathology images and results an integrated part of the imaging patient record.
October 18, 2022
Nobel Prize Winner's Impact on Medical Community
How click chemistry and bioorthogonal chemistry are transforming the pharmaceutical and material industries.
October 13, 2022
City of Hope Installs Momentum Magnetic Particle Imaging Scanner
The goal is for City of Hope researchers to help develop MPI so that it could allow clinicians to directly image cell therapies.
October 11, 2022
Boston Cell Claims First-Ever FDA Approval for Anatomic Pathology Controls
IHControls help ensure that all IHC tests, on all patient samples, are performed correctly.
October 6, 2022
Jasper Health and Scripps Research to Partner on Oncology Research
The partnership's research will be focused on the role of biometrics data in cancer patients.
October 4, 2022
Is It Time for a New Guideline for Medical Guidelines?
Medical guidelines that embrace the humility of uncertainty could help doctors choose treatments with more research evidence behind them.
October 4, 2022
Delphinus Raises $30M for 3D Ultrasound Tomography System
SoftVue is indicated for use as an adjunct to digital mammography in the screening of asymptomatic women with dense breast tissue
September 30, 2022
Sierra Space to Develop Stem Cell Research Institute in Space
The focus will be on biomanufacturing, biofabrication and related in-space laboratory capabilities.
September 29, 2022
Optellum Raises $14M for AI-Based Lung Cancer Diagnosis Platform
Optellum's solution is being used to predict at-risk lung nodules in a multi-center study.
September 27, 2022
Karmanos Cancer Institute First to Get SoftVue Breast Imaging System
A SoftVue mammogram uses warm water and ultrasound technology to create a 3D image of the whole breast.
September 26, 2022
Radical New Treatment System Lights Up Cancer Therapy
Conventional photodynamic techniques depend on the formation of reactive oxygen species to destroy tumor cells.
September 20, 2022
Muscular Dystrophy Association Announces 70 Research Grants
Each grant impacts neuromuscular disease research in a different way.
September 19, 2022
New Wearable Device Measures the Changing Size of Tumors Below the Skin
Each year researchers test thousands of potential cancer drugs on mice with subcutaneous tumors.
September 19, 2022